Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
Department of Microbiology, University of Karachi, Karachi, Pakistan.
J Med Microbiol. 2021 Dec;70(12). doi: 10.1099/jmm.0.001459.
Invasive infections with are a global concern due to poor clinical outcomes and propensity to acquire resistance to antifungal agents Monitoring emerging resistance and trends in , an important agent of candidemia in Pakistan, is critical for patient management; data that is missing from Pakistan Thus, this study evaluated antifungal resistance and MICs) distribution in invasive isolates from Pakistan This cross-sectional and retrospective study was conducted from January 2009 to March 2020 at a clinical laboratory in Pakistan that has a nation-wide network. Antifungal susceptibility data of 277 candidemia, deep organ and soft tissue (invasive) isolates against fluconazole, itraconazole, voriconazole, posaconazole, anidulafungin, micafungin, caspofungin and amphotericin B was retrieved. Susceptibility testing was performed using colorimetric broth microdilution and interpreted using CLSI criteria. Demographics, clinical history and outcome were studied. Chi-square test was used to demonstrate association between antifungal resistance and clinical characteristics of the patients We identified 277 patients with invasive infection. Of which 48 (18.4%) isolates were resistant to fluconazole (MIC ≥64 mg l), one isolate each was resistant to amphotericin (MIC=2 mg l), anidulafungin (MIC=1 mg l) and micafungin (MIC=0.5 mg l). MIC for fluconazole was 64 mg l and other triazoles 2 mg l, caspofungin 0.12 mg l, anidulafungin 0.06 mg l, micafungin 0.03 mg l and amphotericin 0.5 mg l. Fluconazole MIC ≥64 mg l, caspofungin MIC >0.06 mg l and amphotericin MIC >0.25 mg l (above MIC) were significantly associated with patient being alive at the time of reporting, no use of healthcare devices, nor infection with other fungi. Fluconazole resistance was significantly associated with prior antifungal use by the patient Surveillance data of antifungal resistance among common species should be monitored closely for identification of resistant strains.
由于临床结局不佳和对抗真菌药物产生耐药性的倾向,侵袭性感染成为一个全球性问题。监测新出现的耐药性和趋势,对于管理患者至关重要。在巴基斯坦, 是念珠菌血症的重要病原体,但巴基斯坦缺乏这方面的数据。因此,本研究评估了来自巴基斯坦的侵袭性 分离株的抗真菌耐药性和 MIC 分布。这项横断面和回顾性研究于 2009 年 1 月至 2020 年 3 月在巴基斯坦的一个临床实验室进行,该实验室在全国范围内拥有网络。检索了 277 例念珠菌血症、深部器官和软组织(侵袭性)分离株对氟康唑、伊曲康唑、伏立康唑、泊沙康唑、阿尼达弗林、米卡芬净、卡泊芬净和两性霉素 B 的抗真菌药敏数据。使用比色肉汤微量稀释法进行药敏试验,并根据 CLSI 标准进行解释。研究了人口统计学、临床病史和结局。卡方检验用于显示抗真菌耐药性与患者临床特征之间的关联。我们鉴定了 277 例侵袭性 感染患者。其中 48 例(18.4%)分离株对氟康唑(MIC≥64mg/L)耐药,1 例对两性霉素(MIC=2mg/L)、阿尼达弗林(MIC=1mg/L)和米卡芬净(MIC=0.5mg/L)耐药。氟康唑的 MIC 为 64mg/L,其他三唑类药物的 MIC 为 2mg/L,卡泊芬净的 MIC 为 0.12mg/L,阿尼达弗林的 MIC 为 0.06mg/L,米卡芬净的 MIC 为 0.03mg/L,两性霉素的 MIC 为 0.5mg/L。氟康唑 MIC≥64mg/L、卡泊芬净 MIC>0.06mg/L 和两性霉素 MIC>0.25mg/L(高于 MIC)与报告时患者存活、未使用医疗保健设备以及未感染其他真菌显著相关。氟康唑耐药与患者先前使用抗真菌药物显著相关。应密切监测常见 种的抗真菌耐药监测数据,以识别耐药菌株。